216 related articles for article (PubMed ID: 11055823)
1. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis.
Shimizu T; Tomita Y; Son K; Nishinarita S; Sawada S; Horie T
Clin Rheumatol; 2000; 19(5):352-9. PubMed ID: 11055823
[TBL] [Abstract][Full Text] [Related]
2. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis.
Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T
Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis.
Samsonov MY; Nassonov EL; Tilz GP; Geht BM; Demel U; Gurkina GT; Shtutman VZ; Guseva AG; Wachter H; Fuchs D
Br J Rheumatol; 1997 Jun; 36(6):656-60. PubMed ID: 9236675
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.
Gabay C; Gay-Croisier F; Roux-Lombard P; Meyer O; Maineti C; Guerne PA; Vischer T; Dayer JM
Arthritis Rheum; 1994 Dec; 37(12):1744-51. PubMed ID: 7986220
[TBL] [Abstract][Full Text] [Related]
5. Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity.
Mielnik P; Chwalinska-Sadowska H; Wiesik-Szewczyk E; Maslinski W; Olesinska M
Rheumatol Int; 2012 Mar; 32(3):639-43. PubMed ID: 21132303
[TBL] [Abstract][Full Text] [Related]
6. The TNF-alpha system in heart failure and after heart transplantation: plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity.
van Riemsdijk-van Overbeeke IC; Baan CC; Niesters HG; Hesse CJ; Loonen EH; Balk AH; Maat AP; Weimar W
Eur Heart J; 1999 Jun; 20(11):833-40. PubMed ID: 10329082
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-35: A Serological Biomarker for Patients with Polymyositis/Dermatomyositis.
Jiang Q; Li Y; Xia L; Shen H; Lu J
J Interferon Cytokine Res; 2019 Nov; 39(11):720-725. PubMed ID: 31274382
[TBL] [Abstract][Full Text] [Related]
8. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents.
Moon YS; Kim DH; Song DK
Metabolism; 2004 Jul; 53(7):863-7. PubMed ID: 15254878
[TBL] [Abstract][Full Text] [Related]
9. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course.
Spielmann S; Kerner T; Ahlers O; Keh D; Gerlach M; Gerlach H
Acta Anaesthesiol Scand; 2001 Mar; 45(3):364-70. PubMed ID: 11207475
[TBL] [Abstract][Full Text] [Related]
10. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
[TBL] [Abstract][Full Text] [Related]
11. [A study on early activation of T lymphocytes and soluble tumor necrosis factor receptor in patients with myelodysplastic syndrome].
Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J
Zhonghua Nei Ke Za Zhi; 2003 Dec; 42(12):857-60. PubMed ID: 14728878
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor alpha (TNF-alpha)-converting enzyme (TACE) and soluble TNF-alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
Serwin AB; Sokolowska M; Chodynicka B
Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):130-4. PubMed ID: 17598866
[TBL] [Abstract][Full Text] [Related]
13. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
14. [Effects of high-volume hemofiltration on serum levels of tumor necrosis factor and its receptors in patients with multiple organ dysfunction syndromes].
Zhang J; Tao LJ; Ning JP; Xu H; Ai YH; Zhao SP
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Feb; 16(2):81-4. PubMed ID: 14764220
[TBL] [Abstract][Full Text] [Related]
15. Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener's granulomatosis.
Jónasdóttir O; Petersen J; Bendtzen K
APMIS; 2001 Nov; 109(11):781-6. PubMed ID: 11900058
[TBL] [Abstract][Full Text] [Related]
16. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Szymański L
Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis.
Martino G; Consiglio A; Franciotta DM; Corti A; Filippi M; Vandenbroeck K; Sciacca FL; Comi G; Grimaldi LM
J Neurol Sci; 1997 Nov; 152(1):51-61. PubMed ID: 9395126
[TBL] [Abstract][Full Text] [Related]
18. The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.
Loppnow H; Werdan K; Werner C
Auton Autacoid Pharmacol; 2002 Apr; 22(2):83-92. PubMed ID: 12568125
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria.
Grzanka R; Damasiewicz-Bodzek A; Kasperska-Zajac A
Allergy Asthma Clin Immunol; 2019; 15():15. PubMed ID: 30911316
[TBL] [Abstract][Full Text] [Related]
20. Serum-soluble TRAIL: a potential biomarker for disease activity in myositis patients.
Zhou H; Wang Y; Bi K; Qi H; Song S; Zhou M; Chen L; Wang G; Duan T
Clin Rheumatol; 2019 May; 38(5):1425-1431. PubMed ID: 30645753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]